David Louis Johnson Insider Profile
4 Followers
David Louis Johnson, CFO at Oncotelic Therapeutics, holds 0.00 shares in Oncotelic Therapeutics (Ticker: OTLC), holds 48.38K shares in Dynavax (Ticker: DVAX).
David Louis Johnson's Trading History
| DVAXDynavax | Mar 16, 2020 | ― | Uninformative Sell | 47.87K | $749.89K | |
| OTLCOncotelic Therapeutics | ― | CFO | ― | $0.00 |
You May Also Like
David Louis Johnson insider profile FAQ
What is the percentage of profitable transactions made by David Louis Johnson?
The percentage of profitable transactions made by David Louis Johnson is 100%.
What is the average return per transaction made by David Louis Johnson?
The average return per transaction made by David Louis Johnson is 52.00%.
What stocks does David Louis Johnson hold?
David Louis Johnson holds: OTLC, DVAX stocks.
What was David Louis Johnson's most profitable transaction?
David Louis Johnson’s most profitable transaction was an Informative Sell of DVAX stock on March 1, 2019. The return on the trade was 57.20%.
What is David Louis Johnson's role in Oncotelic Therapeutics?
David Louis Johnson's role in Oncotelic Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
